CurrentRheuma coverage · page 2 of 6

Scandinavian Journal of Rheumatology

Briefs 41–80 of 212 CurrentRheuma has covered from this journal, newest publication first

Latest from Scandinavian Journal of Rheumatology

All coverage, newest first

Scand J Rheumatol13 Jan 2026
Is the decision maker a key determinant of colchicine withdrawal success in paediatric heterozygous familial Mediterranean fever patients?
Cohort studyPediatric
Scand J Rheumatol9 Dec 2025
Sensitive detection of plasma interferon regulatory factor-5 (IRF5) by solid-phase proximity ligation assay validates IRF5 high and low subgroups in patients with systemic lupus erythematosus
Diagnostic or prognostic studyLupus & APS
Scand J Rheumatol13 Nov 2025
Burden of disease and treatment patterns for psoriatic arthritis in Finland: a nationwide real-world evidence study
Cohort studySpondyloarthritis & PsA
Scand J Rheumatol10 Nov 2025
Assessing cervical rotation in ankylosing spondylitis: iPhone Compass versus traditional tools
Research articleSpondyloarthritis & PsA
Scand J Rheumatol10 Nov 2025
A multidisciplinary lifestyle programme for patients with rheumatoid arthritis and metabolic syndrome-associated osteoarthritis: economic evaluation alongside the ‘Plants for Joints’ randomized controlled trials
Randomized controlled trialRA
Scand J Rheumatol10 Nov 2025
Psychometric evaluation of the Norwegian version of the Revised Fibromyalgia Impact Questionnaire
Diagnostic or prognostic studyFibromyalgia & pain
Scand J Rheumatol5 Nov 2025
Progression of atherosclerotic plaques over 3 years in patients with systemic lupus erythematosus is inversely associated with continuous hydroxychloroquine treatment
Cohort studyLupus & APS
Scand J Rheumatol4 Nov 2025
Cancer risk in patients with systemic lupus erythematosus: a population-based cohort study in the Republic of Korea 2004–2021
Cohort studyLupus & APS
Scand J Rheumatol4 Nov 2025
Myeloperoxidase–anti-neutrophil cytoplasmic antibody positivity and disease characteristics, treatment, and prognosis in eosinophilic granulomatosis with polyangiitis
Cohort studyVasculitis & PMR
Scand J Rheumatol4 Nov 2025
Signalling profile of circulating leucocytes of subjects with Raynaud’s phenomenon in relation to systemic sclerosis: a pilot study
Mechanistic studySystemic sclerosis
Scand J Rheumatol8 Oct 2025
Validity and reliability of the Danish and Swedish versions of the Bristol Rheumatoid Arthritis Fatigue Questionnaires in patients with spondyloarthritis
Diagnostic or prognostic studySpondyloarthritis & PsA
Scand J Rheumatol10 Sep 2025
Development and validation of a measure of sensory sensitivity – the Sensory Sensitivity Profile: a Rasch analysis
Diagnostic or prognostic studyFibromyalgia & pain
Scand J Rheumatol9 Sep 2025
Are we screening effectively? A systematic review and meta-analysis of proposed risk factors for rheumatoid arthritis-associated interstitial lung disease screening
Meta-analysisRA
Scand J Rheumatol9 Sep 2025
Lacrimal gland ultrasonography shows superior reliability of OMERACT colour Doppler scoring compared to B-mode, in patients with clinically suspected Sjögren’s disease
Research articleSjögren's & overlap
Scand J Rheumatol1 Sep 2025
Known and less well-known comorbidities in axial spondyloarthritis: what are we overlooking? Results from the SPARTAKUS cohort
Cohort studySpondyloarthritis & PsA
Scand J Rheumatol29 Aug 2025
Understanding the use of thermography and its ability to predict ultrasound-detected joint inflammation at the metacarpophalangeal joint in patients with rheumatoid arthritis
Cross-sectional studyRA
Scand J Rheumatol29 Aug 2025
Is there an association between anti-inflammatory medical treatments for rheumatoid arthritis and mortality after first myocardial infarction?
Cohort studyRA
Scand J Rheumatol13 Aug 2025
Calprotectin (S100A8/A9) is not associated with ultrasound-detected synovitis in a longitudinal study of patients with psoriatic arthritis treated with biological disease-modifying anti-rheumatic drugs
Cohort studySpondyloarthritis & PsA
Scand J Rheumatol11 Aug 2025
Similar gout flare incidence rates when using once- or twice-daily 0.5 mg colchicine prophylaxis after the start of xanthine oxidase inhibitors
Cohort studyGout & crystals
Scand J Rheumatol11 Aug 2025
Differentiating familial Mediterranean fever attacks from acute appendicitis in children: which laboratory parameters are useful?
Diagnostic or prognostic studyPediatric
Scand J Rheumatol3 Jul 2025
Ratio between biological and targeted synthetic disease-modifying anti-rheumatic drugs and glucocorticoid use in various countries: results from METEOR
Cross-sectional studyRA
Scand J Rheumatol3 Jul 2025
Impact of tumour necrosis factor-α inhibitors on non-invasive indices of hepatic steatosis and fibrosis in patients with ankylosing spondylitis
Cohort studySpondyloarthritis & PsA
Scand J Rheumatol30 Jun 2025
From confusion to acceptance: overcoming challenges using a fighting spirit and the power of support – a qualitative study of young adults’ experiences in the first year after diagnosis in early onset of chronic inflammatory joint disease
Research article
Scand J Rheumatol30 Jun 2025
Genetically predicted serum urate and cancer risk: a Mendelian randomization study
Research articleGout & crystals
Scand J Rheumatol23 Jun 2025
Limited reduction of bone mineral density in patients with early rheumatoid arthritis receiving aggressive treatment: 10 year results of the NEO-RACo study
Secondary analysisRA
Scand J Rheumatol18 Jun 2025
Dietary intake is related to disease activity and inflammation in radiographic axial spondyloarthritis: a cross-sectional multi-regional study
Cross-sectional studySpondyloarthritis & PsA
Scand J Rheumatol5 Jun 2025
Prophylactic colchicine for familial Mediterranean fever: response rates revisited
Cohort studyAutoinflammatory & rare
Scand J Rheumatol3 Jun 2025
Activation status of circulating neutrophils in gout patients
Mechanistic studyGout & crystals
Scand J Rheumatol3 Jun 2025
Role of rheumatoid arthritis flare in the risk of Alzheimer’s disease and related dementias: a population-based cohort study
Cohort studyRA
Scand J Rheumatol3 Jun 2025
Pulmonary function trajectories in rheumatoid arthritis-associated interstitial lung disease
Cohort studyRA
Scand J Rheumatol21 May 2025
Pretreatment absolute monocyte counts are associated with biological disease-modifying anti-rheumatic drug non-response in patients with rheumatoid arthritis
Cohort studyRA
Scand J Rheumatol8 May 2025
Non-inflammatory macrophages phagocytose and hydrolyse monosodium urate crystals in different stages of gout
Mechanistic studyGout & crystals
Scand J Rheumatol6 May 2025
Dysregulated serum lipid profile and atherosclerosis in untreated female Takayasu arteritis patients: a propensity score-matched analysis
Cross-sectional studyVasculitis & PMR
Scand J Rheumatol24 Apr 2025
Exploratory study of predictors of decreased ability to perform activities of daily living in people living with hand osteoarthritis
Cross-sectional studyOsteoarthritis
Scand J Rheumatol3 Apr 2025
Translation, cross-cultural adaptation, and reliability of the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire in a Danish population
Research articleSystemic sclerosis
Scand J Rheumatol2 Apr 2025
A preceptorship programme to learn ultrasonography for diagnosis of giant cell arteritis
Research articleVasculitis & PMR
Scand J Rheumatol24 Mar 2025
Evaluation of therapeutic plasma exchange in anti-neutrophil cytoplasmic antibody-associated vasculitis in real-life settings: long-term results of propensity score matching analysis in high-risk patients
Cohort studyVasculitis & PMR
Scand J Rheumatol20 Mar 2025
Sex differences in treatment response in patients with rheumatoid arthritis treated with tumour necrosis factor inhibitor: a cohort study from the DANBIO registry
Cohort studyRA
Scand J Rheumatol13 Mar 2025
Cardiovascular risk and cardiac involvement in idiopathic inflammatory myopathies: insights from a cross-sectional Swedish single-centre study
Cross-sectional studyMyositis
Scand J Rheumatol3 Mar 2025
Risk of cardiovascular diseases and gastrointestinal bleeding is comparable between celecoxib and non-selective non-steroidal anti-inflammatory drugs in patients with ankylosing spondylitis: a nationwide retrospective cohort study
Cohort studySpondyloarthritis & PsA

All 212 Briefs in ExploreShowing Briefs 41–80 of 212, newest first